Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
KR |
|
L
|
Liniu Technology Group
OTC:LINUF
|
MO |
|
Newfoundland Discovery Corp
OTC:NEWDF
|
CA |
|
B
|
BlossomHill Therapeutics Inc
NASDAQ:BLSM
|
US |
|
Insperity Inc
NYSE:NSP
|
US |
|
N
|
Nordson Corp
SWB:ND1
|
US |
|
G
|
G Beneficial Inc
OTC:GBEN
|
US |
|
Anfield Energy Inc
XTSX:AEC
|
CA |
|
O
|
Oppstar Bhd
KLSE:OPPSTAR
|
MY |
|
V
|
Vastland Indonesia PT Tbk
IDX:VAST
|
ID |
|
Q
|
Quest for Growth NV
LSE:0FRE
|
BE |
|
S
|
Super Bank Indonesia Tbk PT
IDX:SUPA
|
ID |
|
I
|
Invesco Ltd
SWB:3IW
|
US |
|
Mechel PAO
MOEX:MTLRP
|
RU |
|
A
|
Allegion PLC
SWB:60A
|
IE |
|
D
|
Duta Pertiwi Nusantara Tbk PT
IDX:DPNS
|
ID |
|
E
|
Everest Global PLC
LSE:EVST
|
UK |
|
Naigai Tec Corp
TSE:3374
|
JP |
|
I
|
Impact Silver Corp
OTC:ISVLF
|
CA |
|
Highfield Resources Ltd
ASX:HFR
|
AU |
|
Real Brands Inc
OTC:RLBD
|
US |
Bankruptcy Probability
Optus Pharmaceutical Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Optus Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
103.2B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Essilorluxottica SA
PAR:EL
|
83.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
8.7T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
45.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
28.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
108B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Solventum Corp
NYSE:SOLV
|
14.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cooper Companies Inc
NASDAQ:COO
|
11.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
6.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Optus Pharmaceutical Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Optus Pharmaceutical Co Ltd has total debt of 517.9m KRW. This includes both short-term (0 KRW) and long-term (517.9m KRW) debt.
You can find a full breakdown on its Balance Sheet.